Anti-aging Scientific Advisory Board
Lars Bohlin, Ph.D.
Professor of Pharmacognosy, University of Uppsala, Sweden
For 30 years, Dr. Bohlin has studied, researched, and taught pharmacy. He earned his M.S. and Ph.D. in pharmacy at Uppsala University in Sweden, where he currently serves as a professor on the faculty. He developed marine pharmacognosy in Sweden and his interests have focused on ethnopharmacology with an emphasis on anti-inflammatory natural products. He is widely consulted as an expert by both private and public organizations, and sits on numerous research councils. A native of Stockholm, Sweden, Dr. Bohlin has contributed on many levels— both his own community, serving as the Chairman of the Board for the Department of Pharmacy at Uppsala, and internationally. He sits on editorial or advisory boards for such scientific journals as Phytotherapy Research, Phytomedicine, J. Ethnopharmacology, and Planta Medica.
Pharmaceutical Science Advisor
Dr. Chang received a Ph.D. and M.S in Organic Chemistry from Brandeis University and postdoctoral from MIT. As a scientific advisor to Nu Skin, Dr. Chang is an expert in supplement development. He served as the CEO and president of Optimer Pharmaceuticals, Vice President of Research and Development for Pharmanex, the Director of Medical Chemistry at Rhone-Poulenc Rorer, and Deputy Director of Medicinal Chemistry at Merck. He has more than 20 years of pharmaceutical experience and his previous management responsibilities include the direction of several drug discovery projects and IND submissions. His research has resulted in 35 patents and has been the topic of more than 60 articles published in peer-review journals.
Paul Alan Cox, Ph.D.
Director of the Institute for Ethnomedicine
One of the world’s top ethnobotanists, Dr. Cox specializes in the use of plants by indigenous cultures. During his career, he has published more than 150 scientific articles and three books. Dr. Cox received his M.Sc. in ecology at the University of Wales as a Fullbright Fellow. In 1978, Dr. Cox entered Harvard as a Danforth Fellow and National Science Foundation Fellow, and in 1981 he received his Ph.D. in biology. He was later awarded a National Science Foundation Presidential Young Investigator Award by President Ronald Reagan. Currently, Dr. Cox serves as Chairman of the Seacology Foundation, an organization he founded to assist in preserving island rain forests and cultures.
Article by Paul Alan Cox
Zoe Diana Draelos, M.D., F.A.A.D.
Dermatologist and Editor-in-Chief, Journal of Cosmetic Dermatology
Dr. Draelos is a practicing, board-certified dermatologist and a Fellow of the American Academy of Dermatology with a research interest in cosmetics, toiletries and biologically active skin medications. She is a consulting professor in the Department of Dermatology at Duke University School of Medicine and has a clinical practice in High Point, N.C. She has been a visiting professor at more than 45 medical institutions nationally and internationally. She is the author of nine textbooks, including Cosmetics in Dermatology. Dr. Draelos has contributed chapters to 23 textbooks, written 300 published papers, and currently serves on eight journal editorial boards. In 2006, she received a cosmetics industry lifetime achievement award from Health Beauty America for her research contributions in topical formulations.
Bryan Fuller, Ph.D.
Adjunct Professor, Department of Dermatology, University of Oklahoma Health Sciences Center
Dr. Bryan Fuller received a Ph.D. in Cell Biology and Biochemistry from the University of Arizona with aspecialty in molecular endocrinology. For nearly 30 years, Dr. Fuller’s research has focused on under- standing how human skin pigmentation is regulated. His discoveries have resulted in the issuance of 11 U.S. patents as well as additional international patents. He has authored more than 40 peer-reviewed scientific articles on pigmentation, and additional articles and reviews on the development of topical products for regulating pigmentation and controlling inflammation. Dr. Fuller was integrally involved in the development of the Nu Skin® Tri-Phasic White™ line and also conducted testing on the Nu Skin Galvanic Spa™ System II.
Molly Wanner, M.D., M.B.A.
Board Certified Dermatologist specializing in Laser and Cosmetic Dermatology
Massachusetts General Hospital
Instructor in Dermatology, Harvard Medical School
Molly Wanner, M.D., M.B.A., is a board-certified dermatologist who specializes in laser and cosmetic dermatology at Massachusetts General Hospital and is an instructor in dermatology at Harvard Medical School. Dr. Wanner is currently conducting clinical and basic science research in the areas of cosmetic and laser dermatology. Her research interests include topical cosmetic products, fat and cellulite, and laser and cosmetic devices.
Dr. Wanner has presented nationally and authored multiple articles in publications such as Dermatologic Surgery, Lasers in Surgery and Medicine, and Journal of the American Academy of Dermatology. She serves on task forces for the American Academy of Dermatology, the American Society of Dermatologic Surgery, and the Women’s Dermatologic Society. Dr. Wanner also contributes to popular consumer media and has been quoted in outlets such as The New York Times, Cosmetic Surgery Times, and Allure magazine.
Dr. Wanner has presented nationally and authored multiple articles in publications such as Dermatologic Surgery, Lasers in Surgery and Medicine, and Journal of the American Academy of Dermatology. She serves on task forces for the American Academy of Dermatology, the American Society of Dermatologic Surgery, and the Women’s Dermatologic Society. Dr. Wanner also contributes to popular consumer media and has been quoted in outlets such as The New York Times, Cosmetic Surgery Times, and Allure magazine.
Makoto Kuro-o, M.D., Ph.D.
Associate Professor of Pathology, University of Texas Southwestern Medical Center
Dr. Kuro-o received an M.D. in 1985 from the University of Tokyo, Japan. He completed his residency training at Tokyo Metropolitan Geriatric Hospital in 1988, after which he returned to the University of Tokyo as a clinical fellow in cardiology until 1998. He received a Ph.D. in 1991 from the University of Tokyo, following which he pursued postdoctoral training at the National Institute of Neuroscience in Japan. During his postdoctoral work, he identified the klotho gene—an aging suppressor gene in mammals. In 1998, he became an Assistant Professor of Pathology at the University of Texas Southwestern Medical Center at Dallas. His laboratory focuses on understanding the molecular mechanism by which the klotho protein suppresses aging.
Tomas A. Prolla, Ph.D
Co-founder, LifeGen Technologies, Professor, departments of Genetics and Medical Genetics, University of Wisconsin
Tomas A. Prolla, Ph.D., studied in the Department of Molecular Bio-physics and Biochemistry at Yale University, receiving a doctoral degree in 1994. He completed post-doctoral training at the Human and Molecular Genetics Department at Baylor College of Medicine, then joined the faculty of the Department of Genetics and Medical Genetics at the University of Wisconsin in 1997. Dr. Prolla has received several awards of scientific excellence, including the Shorb Lecturer Award, the Burroughs Wellcome Young Investigator Award, the Shaw Scientist Award, the Howard Hughes Medical Institute New Investigator Award, and the Pound Research Award. Dr. Prolla’s work currently focuses on the use of gene expression profiling, lifespan studies, and histopathology. In 2001, he and Dr. Richard Weindruch founded LifeGen Technologies, LLC, a company focused on nutritional genomics, including the impact of nutrients and caloric restriction on the aging process. Dr. Prolla has published several articles in prestigious scientific journals such as Science.
Hildebert Wagner, Ph.D.
Professor Emeritus, Institute of Pharmacy at the Ludwig-Maximilians University Center for Pharmaceutical Research, Munich, Germany
Author of Immunmodulatory Agents from Plants (Birkhauser Verlag, Basel, 1999), Dr. Hildebert Wagner has studied Pharmacy since 1950. He is the author of 7 other books including: Plant Drug Analysis (Springer Verlag Heidelber, 1996), and Drugs and Drug Constituents (Wissenschaftliche Verlagsgesellschaft Stuttgart, 1998), as well as authoring over 900 other scientific publications. Dr. Wagner was made a Full Professor of Pharmacognosy in 1965, and later served as Director of the Institute of Pharmaceutical Biology in Munich until 1999. He has been distinguished by many international scientific institutions including the Universities of Ohio, Budapest and Debrecen, Dijon, and Helsinki for his work in Pharmacy. Dr. Wagner sits on advisory/editorial boards for Phytochemistry, the Journal of Ethnopharmacology, the Journal of Natural Products, as well as serving as Editor for the International Journal of Phytomedicine.